Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
09/2002
09/11/2002EP1237852A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002EP1177199B1 Ionic liquids and production and use thereof
09/11/2002EP0958287B1 Sulfamide-metalloprotease inhibitors
09/11/2002EP0813529B1 Arginine analogues having nitric oxide synthase inhibitor activity
09/11/2002EP0799206B1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
09/11/2002EP0736009B1 N-oxides of 4-arylpiperazines and 4-arylpiperidines as antipsychotic drugs
09/11/2002CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives
09/11/2002CN1368956A Carbamate derivatives and agricultural/horticultural bactericides
09/11/2002CN1368498A Preparation method of o-chloromethyl phenyl glyoxalic acid derivative
09/11/2002CN1368497A Preparation method of o-chloromethyl phenyl glyoxalic acid derivative
09/11/2002CN1090480C Phenoxy piperazine derivatives for treating disorders of dopamine system
09/10/2002US6448445 Method for catalytically disubstituting carboxylic acid amides with at least one grignard reagent
09/10/2002US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/10/2002US6448293 Treatment or prevention of a disorder in which the regulation of monoamine transporter function is implicated, such as premature ejaculation.
09/10/2002US6448250 Sulfamato hydroxamic acid metalloprotease inhibitor
09/10/2002US6448244 Broad-spectrum antifungals, against which there is no existing resistance and which can be administered intravenously or transungually
09/10/2002US6448243 Serotonin antagonist for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia
09/10/2002US6448242 Cyclic amide compounds
09/10/2002US6447748 Benzamide compounds for cancer imaging and therapy
09/10/2002CA2239159C Acylated enol derivatives of .alpha.-ketoesters and .alpha.-ketoamides
09/10/2002CA2198562C Method of treating conditions with estrogen agonists
09/06/2002WO2002068399A1 Aryl carbamate derivatives, preparation and use thereof
09/06/2002WO2002068390A1 Diamides which inhibit tryptase and factor xa activity
09/06/2002WO2002068381A2 Aryl-n-cyanoguanidines and methods related thereto
09/06/2002WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells
09/06/2002WO2002068367A1 A method to inhibit ethylene responses in plants
09/06/2002WO2002067919A1 Il-8 receptor antagonists
09/06/2002WO2002043648A8 Compounds active at the glucocorticoid receptor ii
09/06/2002WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance
09/06/2002WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors
09/06/2002WO2001018011A9 Calcium complex of phosphorus containing ethylenediamine derivatives
09/06/2002CA2475454A1 Aryl-n-cyanoguanidines and methods related thereto
09/06/2002CA2438828A1 Aryl carbamate derivatives, preparation and use thereof
09/06/2002CA2437114A1 Diamides which inhibit tryptase and factor xa activity
09/05/2002US20020123637 Pharmaceutically active compounds and methods of use thereof
09/05/2002US20020123498 For inhibiting transport protein; therapy
09/05/2002US20020123489 Benzamidine derivatives
09/04/2002EP1236723A1 Sulfamide derivatives useful as beta3 agonists and pharmaceutical uses thereof
09/04/2002EP1236722A1 Optically active 4-(tert-butoxycarbonyl) piperazine compound, and method for producing the same
09/04/2002EP1235831A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
09/04/2002EP1235807A1 B-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa
09/04/2002EP1235793A2 Vla-4 integrin antagonists
09/04/2002EP1235776A1 Triphenylalkene derivatives and their use as selective estrogen receptor modulators
09/04/2002EP1235764A1 Catalysis using phosphine oxide compounds
09/04/2002EP1235575A2 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
09/04/2002EP0635008B1 Piperazides of substituted phenylalanine derivates as thrombin inhibitors
09/04/2002CN1367783A Antipsychotic cyclic N-aralkyl amines
09/03/2002US6444819 Benzylpiperazinyl and piperidinyl ethanone derivatives: dopamine receptor subtype specific ligands
09/03/2002US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/03/2002US6444701 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
09/03/2002US6444678 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
09/03/2002US6444190 Slurry of a sodium aluminum hydride, lithium or titanium containing additive and a lewis base in solvent; non-pyrophoric; thermal stability
09/03/2002CA2140626C Hydroxamic acid derivatives as metalloproteinase inhibitors
09/01/2002CA2373578A1 .beta.3, agonists and uses thereof
09/01/2002CA2356201A1 Compounds and compositions for delivering active agents
08/2002
08/29/2002WO2002066469A2 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066451A2 1,2-diphenyl-1-naphthyl ethene derivatives, analogs and use thereof
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066432A1 Substituted propane-1,3-diamine derivatives and the pharmaceutical use thereof
08/29/2002WO2002066428A2 Non-steroidal estrogen receptor ligands
08/29/2002WO2002066422A1 Phenethanolamine derivatives for treatment of respiratory diseases
08/29/2002WO2002066415A2 Non-steroidal modulators of estrogen receptors
08/29/2002WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/29/2002WO2002002520A3 Compounds to treat alzheimer's disease
08/29/2002WO2002002506A3 Compounds to treat alzheimer's disease
08/29/2002WO2001012584A3 Pharmaceutical compounds
08/29/2002WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
08/29/2002US20020120140 Phosgene-free process for preparing carbamates
08/29/2002US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
08/29/2002US20020120007 Benzamide inhibitors of factor Xa
08/29/2002US20020119988 Modulators of TNF-alpha signaling
08/29/2002US20020119979 Cancer therapy
08/29/2002US20020119960 Drug resistance therapy
08/29/2002US20020119953 Sickle cell anemia
08/29/2002US20020119910 Drug delivery
08/29/2002DE19941540C2 Sulfonylcarboxamide zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Hyperlipidämie Sulfonylcarboxamide for the preparation of medicaments for the prophylaxis or treatment of hyperlipidemia
08/29/2002DE10108307A1 Substituierte Propan-1,3-diamin-Derivate Substituted propane-1,3-diamine derivatives
08/29/2002CA2438318A1 Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2438264A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002CA2437977A1 Phenethanolamine derivatives for treatment of respiratory diseases
08/28/2002EP1233961A2 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination
08/28/2002EP1233955A1 Process for preparing piperazine-substituted aliphatic carboxylates
08/28/2002EP1233954A1 A process for the preparation of 2- 4-(alpha-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy acetic acid and novel intermediates therefor
08/28/2002EP0868202B1 Cascade polymer complexes, process for producing the same and pharmaceuticals containing the same
08/28/2002CN1366518A Biphenyl butyric acid derivative as matrix metalloproteinase inhibitor
08/27/2002US6441237 Drugs; antiarrhthymia agents, antiischemic agents
08/27/2002US6441193 Intermediates such as 1-(2-(4-(6-methoxy-3,4-dihydronaphtha-len-1-yl)phenoxy)ethyl)pyrrolidine and compounds such as cis-6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol, hydrobromide salt
08/27/2002US6441179 Intermediates useful for the preparation of antihistaminic piperidine derivatives
08/27/2002US6441049 Administering compound effective to inhibit binding of an amyloid beta peptide with alpha-7 nicotinic acetylcholine receptors
08/27/2002US6441042 Hydroxamic acid derivatives as antibacterials
08/27/2002US6441023 For therapy of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and hiv infection
08/27/2002CA2224738C Use of ritonavir (abt-538) for improving the pharmacokinetics of drugs metabolized by cytochrome p450 in a method of treating aids
08/22/2002WO2002064576A1 Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
08/22/2002WO2002064551A1 Hiv protease inhibitors based on amino acid derivatives
08/22/2002WO2002064550A1 Glucocorticoid receptor modulators
08/22/2002WO2002064546A2 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical
08/22/2002WO2002064545A1 Acylated indanyl amines and their use as pharmaceuticals